Ge healthcare drives growth with investment in ai-enabled medical devices and tops fda's list of ai authorizations for 4th year with 100

Chicago--(business wire)--ge healthcare (nasdaq: gehc) has topped a u.s. food and drug administration (fda) list of ai-enabled medical device authorizations for the fourth year in a row with 100 listed authorizations to date in the u.s. this milestone reflects ge healthcare's continued research and development (r&d) investment and focus on developing ai solutions to advance precision care by enhancing medical devices across the care journey. smart devices, software, and cloud-based solution.
GEHC Ratings Summary
GEHC Quant Ranking